Article

HPTLC methods to assay active ingredients in pharmaceutical formulations: a review of the method development and validation steps.

Tanzania Food and Drugs Authority, P.O. Box 77150, Dar es Salaam, Tanzania; School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65013, Dar es Salaam, Tanzania; Department of Analytical Chemistry and Pharmaceutical Technology (FABI), Center for Pharmaceutical Research (CePhaR), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium.
Journal of pharmaceutical and biomedical analysis (Impact Factor: 2.45). 03/2012; 66:11-23. DOI: 10.1016/j.jpba.2012.03.034
Source: PubMed

ABSTRACT High-performance thin-layer chromatography (HPTLC) is still increasingly finding its way in pharmaceutical analysis in some parts of the world. With the advancements in the stationary phases and the introduction of densitometers as detection equipment, the technique achieves for given applications a precision and trueness comparable to high-performance liquid chromatography (HPLC). In this review, the literature is surveyed for developed and validated HPTLC methods to assay active ingredients in pharmaceutical formulations published in the period 2005-2011. Procedures and approaches for method development, validation and quantitative assays are compared with the standard ways of conducting them. Applications of HPTLC in some other areas are also briefly highlighted.

0 Bookmarks
 · 
173 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Novel, simple and sensitive high performance thin-layer chromatography (HPTLC) with fluorescence detection has been successfully developed and validated for determination of gemifloxacin mesylate (GFX) in plasma samples without prior pretreatment. Montelukast (MK) was used as internal standard. GFX and MK in plasma samples were separated using a mobile phase consisting of a mixture of ethyl acetate:methanol:25% ammonia, (8:4.5:3, v/v/v). The emission intensity was measured using optical filter K400 after excitation at 342nm. The Rf values for GFX and MK were 0.45±0.03 and 0.79±0.02, respectively. Under the optimum conditions, a linear relationship with good correlation coefficient (r=0.9965, n=6) was obtained in concentration range of 3-180ng/band. The LOD and LOQ of the proposed method were 0.45 and 1.5ng/band, respectively. The accuracy of the method was proved as the recovery % of GFX from spiked human plasma was 94.21-101.85%. The efficiency of the proposed method was confirmed by in-vivo application on human plasma in real patient samples. Moreover, the stability of GFX in plasma was carefully tested at different conditions and compared to others in aqueous solution.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 07/2014; 967C:98-101. · 2.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A simple, sensitive and robust high performance thin layer chromatography method for determination of fluvastatin sodium in capsules dosage form has been developed and validated. Fluvastatin sodium from the HPTLC plates as a stationary phase using methanol–ethyl acetate-toluene-glacial acetic acid (3:5:1.8:0.2, v/v/v/v) as mobile phase. Densitometry scanning was performed in absorbance mode at 235 nm. Well-resolved bands were obtained of fluvastatin sodium in bulk and capsules dosage form. The plates were developed to a distance of 8 cm. Percentage relative standard deviation of intra-day and inter day precision, were found 0.59 -0.95% and 0.9 -1.73 % respectively. Statistical analysis proved that the method was precise, accurate and robust. The limits of detection and quantification were 26.74 and 81.05ng/band. The method was fully validated for linearity, specificity, accuracy, precision, repeatability, and robustness to prove its suitability for determination of fluvastatin sodium in bulk and capsule dosage form in accordance with ICH guidelines.
    International Journal of Pharmaceutical Research. 04/2014; 6(2):73.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A simple, sensitive and robust high performance thin layer chromatography method for determination of fluvastatin sodium in capsules dosage form has been developed and validated. Fluvastatin sodium from the formulations was separated and identified on aluminium backed silica gel 60 F254 HPTLC plates as a stationary phase using methanol–ethyl acetate-toluene-glacial acetic acid (3:5:1.8:0.2, v/v/v/v) as mobile phase. Densitometry scanning was performed in absorbance mode at 235 nm. Well-resolved bands were obtained of fluvastatin sodium in bulk and capsules dosage form. The plates were developed to a distance of 8 cm. Percentage relative standard deviation of intra-day and inter day precision, were found 0.59 -0.95% and 0.9 -1.73 % respectively. Statistical analysis proved that the method was precise, accurate and robust. The limits of detection and quantification were 26.74 and 81.05ng/band. The method was fully validated for linearity, specificity, accuracy, precision, repeatability, and robustness to prove its suitability for determination of fluvastatin sodium in bulk and capsule dosage form in accordance with ICH guidelines.
    International Journal of Biological & Pharmaceutical Research 07/2014; 6(2):73-78.

Full-text

View
141 Downloads
Available from
May 21, 2014